[go: up one dir, main page]

DE69923906D1 - Verfahren zur Herstellung von Pyrazolo-(4,3-d)pyrimidin-7-ones und Zwischenprodukte davon - Google Patents

Verfahren zur Herstellung von Pyrazolo-(4,3-d)pyrimidin-7-ones und Zwischenprodukte davon

Info

Publication number
DE69923906D1
DE69923906D1 DE69923906T DE69923906T DE69923906D1 DE 69923906 D1 DE69923906 D1 DE 69923906D1 DE 69923906 T DE69923906 T DE 69923906T DE 69923906 T DE69923906 T DE 69923906T DE 69923906 D1 DE69923906 D1 DE 69923906D1
Authority
DE
Germany
Prior art keywords
pyrazolo
pyrimidin
intermediates
ones
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69923906T
Other languages
English (en)
Other versions
DE69923906T2 (de
Inventor
Peter James Dunn
Philip Charles Levett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ireland Pharmaceuticals
Original Assignee
Pfizer Ireland Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10840421&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69923906(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Ireland Pharmaceuticals filed Critical Pfizer Ireland Pharmaceuticals
Publication of DE69923906D1 publication Critical patent/DE69923906D1/de
Application granted granted Critical
Publication of DE69923906T2 publication Critical patent/DE69923906T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69923906T 1998-10-12 1999-10-11 Verfahren zur Herstellung von Pyrazolo-(4,3-d)pyrimidin-7-ones und Zwischenprodukte davon Expired - Lifetime DE69923906T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9822238 1998-10-12
GBGB9822238.3A GB9822238D0 (en) 1998-10-12 1998-10-12 Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof

Publications (2)

Publication Number Publication Date
DE69923906D1 true DE69923906D1 (de) 2005-04-07
DE69923906T2 DE69923906T2 (de) 2006-04-06

Family

ID=10840421

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69923906T Expired - Lifetime DE69923906T2 (de) 1998-10-12 1999-10-11 Verfahren zur Herstellung von Pyrazolo-(4,3-d)pyrimidin-7-ones und Zwischenprodukte davon

Country Status (49)

Country Link
US (3) US6207829B1 (de)
EP (1) EP0994115B1 (de)
JP (1) JP3721021B2 (de)
KR (1) KR100380954B1 (de)
CN (2) CN1207295C (de)
AP (1) AP1233A (de)
AR (1) AR019244A1 (de)
AT (1) ATE290003T1 (de)
AU (1) AU756463B2 (de)
BG (1) BG63205B1 (de)
BR (1) BR9905092A (de)
CA (1) CA2285733C (de)
CO (1) CO5150214A1 (de)
CR (1) CR6118A (de)
CU (1) CU22928A3 (de)
CZ (1) CZ296816B6 (de)
DE (1) DE69923906T2 (de)
DK (1) DK0994115T3 (de)
DZ (1) DZ2912A1 (de)
EA (1) EA003774B1 (de)
EE (1) EE04192B1 (de)
EG (1) EG22630A (de)
ES (1) ES2237049T3 (de)
GB (1) GB9822238D0 (de)
GE (1) GEP20022700B (de)
GT (1) GT199900172A (de)
HK (1) HK1027559A1 (de)
HR (1) HRP990318B1 (de)
HU (1) HU226162B1 (de)
ID (1) ID23351A (de)
IL (11) IL152924A (de)
IS (1) IS1951B (de)
MA (1) MA25007A1 (de)
MY (1) MY124620A (de)
NO (1) NO313700B1 (de)
OA (1) OA11165A (de)
PE (1) PE20001086A1 (de)
PL (1) PL198150B1 (de)
PT (1) PT994115E (de)
RS (1) RS49762B (de)
SG (1) SG118060A1 (de)
SI (1) SI0994115T1 (de)
SK (1) SK285215B6 (de)
TN (1) TNSN99189A1 (de)
TR (1) TR199902541A2 (de)
TW (1) TW589314B (de)
UA (1) UA66787C2 (de)
UY (1) UY25750A1 (de)
ZA (1) ZA996412B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078760A1 (fr) * 1999-06-21 2000-12-28 The Biochemical Pharmaceutical Factory Of Zhuhai Sez Procede de preparation de sildenafil, agent et procede d'obtention d'un comprime mixte a base de sildenafil et de chlorhydrate d'apomorphine
AP2001002194A0 (en) * 2000-06-22 2002-12-21 Pfizer Novel process for the preparation of pyrazolopyrimidinones.
US6667398B2 (en) 2000-06-22 2003-12-23 Pfizer Inc Process for the preparation of pyrazolopyrimidinones
US6407259B1 (en) 2000-07-28 2002-06-18 Pfizer Inc. Process for the preparation of pyrazoles
YU51701A (sh) * 2000-07-28 2003-12-31 Pfizer Inc. Postupak za dobijanje jedinjenja pirazola/4,3-d/ pirimidin-7-ona i njihovih derivata
EP1176142A1 (de) * 2000-07-28 2002-01-30 Pfizer Inc. Verfahren zur Herstellung von Pyrazolen
PE20020394A1 (es) 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
US7335680B2 (en) * 2001-12-20 2008-02-26 Laboratoires Serono Sa Pyrrolidine derivatives as prostaglandin modulators
WO2003059258A2 (en) * 2001-12-21 2003-07-24 Cytokinetics, Inc. Compositions and methods for treating heart failure
EP1719772A1 (de) 2002-05-31 2006-11-08 Schering Corporation Verfahren zur Herstellung von Xanthin Phosphodiesterase v Inhibitoren und deren Vorstufen
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
ES2378620T3 (es) 2003-03-27 2012-04-16 Cytokinetics, Inc. Sulfonamidas para el tratamiento de insuficiencia cardiaca congestiva, sus composiciones y usos.
CN100360531C (zh) * 2003-12-18 2008-01-09 中国人民解放军军事医学科学院放射与辐射医学研究所 用于预防或治疗阳萎和性冷淡的新吡唑并嘧啶类化合物
US20070010525A1 (en) * 2005-06-27 2007-01-11 Meyer Jackson Method and compositions for modulating neuropeptide hormone secretion
NL2000291C2 (nl) * 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
EP2024369A4 (de) * 2006-06-05 2010-10-27 Matrix Lab Ltd Neues verfahren zur herstellung von sildenafilcitrat
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN107759603B (zh) * 2016-08-18 2020-09-01 四川科伦药物研究院有限公司 一种杂环化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
IL132276A0 (en) * 1997-04-25 2001-03-19 Pfizer Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cgmp pde5) for the treatment of sexual dysfunction

Also Published As

Publication number Publication date
IL152928A0 (en) 2003-06-24
IL152924A0 (en) 2003-06-24
PL335959A1 (en) 2000-04-25
IL152924A (en) 2004-02-19
GB9822238D0 (en) 1998-12-09
BG103794A (en) 2000-09-29
CZ296816B6 (cs) 2006-06-14
MA25007A1 (fr) 2000-07-01
ZA996412B (en) 2001-04-11
PT994115E (pt) 2005-06-30
TR199902541A2 (xx) 2000-07-21
DK0994115T3 (da) 2005-06-20
JP3721021B2 (ja) 2005-11-30
AU5358199A (en) 2000-04-13
EA199900822A3 (ru) 2000-08-28
GEP20022700B (en) 2002-05-27
EE9900507A (et) 2000-06-15
IS1951B (is) 2004-10-13
CN1255497A (zh) 2000-06-07
HRP990318B1 (en) 2004-06-30
IL152927A (en) 2004-06-01
AR019244A1 (es) 2001-12-26
UA66787C2 (en) 2004-06-15
NO994943L (no) 2000-04-13
ATE290003T1 (de) 2005-03-15
AU756463B2 (en) 2003-01-16
EP0994115A3 (de) 2000-05-24
CO5150214A1 (es) 2002-04-29
HRP990318A2 (en) 2000-06-30
IL152926A0 (en) 2003-06-24
SG118060A1 (en) 2006-01-27
AP9901672A0 (en) 1999-12-31
TW589314B (en) 2004-06-01
BR9905092A (pt) 2000-08-08
SI0994115T1 (de) 2005-08-31
DZ2912A1 (fr) 2004-03-01
IS5209A (is) 2000-04-13
NO994943D0 (no) 1999-10-11
PL198150B1 (pl) 2008-05-30
EA003774B1 (ru) 2003-08-28
IL152927A0 (en) 2003-06-24
IL152923A0 (en) 2003-06-24
ES2237049T3 (es) 2005-07-16
GT199900172A (es) 2001-03-28
TNSN99189A1 (fr) 2005-11-10
CA2285733A1 (en) 2000-04-12
NO313700B1 (no) 2002-11-18
HUP9903469A3 (en) 2000-10-30
EA199900822A2 (ru) 2000-04-24
ID23351A (id) 2000-04-13
SK138599A3 (en) 2000-05-16
CR6118A (es) 2005-09-16
CZ353299A3 (cs) 2000-05-17
IL132273A (en) 2004-06-20
HU9903469D0 (en) 1999-12-28
EP0994115A2 (de) 2000-04-19
US20010009962A1 (en) 2001-07-26
KR100380954B1 (ko) 2003-04-21
DE69923906T2 (de) 2006-04-06
US6207829B1 (en) 2001-03-27
HK1027559A1 (en) 2001-01-19
BG63205B1 (bg) 2001-06-29
CU22928A3 (es) 2004-02-20
OA11165A (en) 2003-04-22
IL132273A0 (en) 2001-03-19
SK285215B6 (sk) 2006-09-07
CA2285733C (en) 2004-08-24
EE04192B1 (et) 2003-12-15
MY124620A (en) 2006-06-30
AP1233A (en) 2003-12-18
IL152923A (en) 2004-02-08
HU226162B1 (en) 2008-05-28
HUP9903469A2 (hu) 2000-08-28
UY25750A1 (es) 2001-08-27
JP2000119273A (ja) 2000-04-25
RS49762B (sr) 2008-04-04
KR20000028987A (ko) 2000-05-25
EG22630A (en) 2003-05-31
CN1473831A (zh) 2004-02-11
EP0994115B1 (de) 2005-03-02
PE20001086A1 (es) 2000-10-18
IL152928A (en) 2007-07-04
CN1207295C (zh) 2005-06-22
IL152926A (en) 2004-02-19
YU48999A (sh) 2002-06-19
US20030069422A1 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
DE69801973D1 (de) Verfahren zur Herstellung von 1,1,1,3,3-Pentafluorpropan
DE69923906D1 (de) Verfahren zur Herstellung von Pyrazolo-(4,3-d)pyrimidin-7-ones und Zwischenprodukte davon
DE69534190D1 (de) Verfahren zur Herstellung von 1,2-Benzisothiazol-3-onen
DE69711120D1 (de) Verfahren zur Herstellung von Dialkylnaphthalinen
DE59608829D1 (de) Verfahren zur Herstellung von 1,3-Dimethyl-5-fluor-pyrazol-4-carboxaniliden
DE59503847D1 (de) Verfahren zur Herstellung von 3,5-Dimethylpyrazol-blockierten Polyisocyanaten
DE69702550D1 (de) Verfahren zur Herstellung von peroxiperfluoropolyxyalkylene
DE59401009D1 (de) Verfahren zur Herstellung von 1,1,1,3,3-Pentafluorpropan
DE69511788D1 (de) Verfahren zur Herstellung von 1,1,1,3,3-Pentafluorpropan
DE59702177D1 (de) Verfahren zur Herstellung von Hydroxymethylcyclopropan
DE59610221D1 (de) Verfahren zur Herstellung von 2-Acetyl-gamma-butyrolacton
DE60017330D1 (de) Verfahren zur Herstellung von 3-pyridylsulphonylpyrazolo[4,3-d]pyrimidin-7-one und Zwischenprodukte
DE69806876D1 (de) Verfahren zur Herstellung von 2-Chlorprop-1-en
DE69703764D1 (de) Verfahren zur Herstellung von N-Acetonylbenzamide
DE69503100D1 (de) Verfahren zur Herstellung von 3,4-Carandiol
DE69508683D1 (de) Verfahren zur Herstellung von 2,6-Di-tert-alkylcyclohexanol
DE69710294D1 (de) Verfahren zur Herstellung von 3,5,5-Trimethyl-Cyclohexa-3-en-1-on
DE69703599D1 (de) Verfahren zur Herstellung von 2-H-Heptafluorpropan
DE59900401D1 (de) Verfahren zur Herstellung von 1,3-Dimethyl-imidazolium-4-carboxylat
DE69840863D1 (de) Verfahren zur Herstellung von 2,6-Diaminopurin-2'deoxyribosid und 2'-Deoxyguanosin
DE59705748D1 (de) Verfahren zur Herstellung von Cyclopentanolen
DE69502242D1 (de) Verfahren zur Herstellung von 1,3-dialkyl-2-imidazolidinon
DE59401657D1 (de) Verfahren zur Herstellung von Cyclopropancarbonsäureamid
DE69807409D1 (de) Verfahren zur Herstellung von 7-Octen-1-al
DE69716203D1 (de) Verfahren zur Herstellung von hochreinem 1,3-Dialkyl-2-imidazolidinon

Legal Events

Date Code Title Description
8363 Opposition against the patent
8328 Change in the person/name/address of the agent

Representative=s name: DERZEIT KEIN VERTRETER BESTELLT